Researchers with MD Anderson’s Colorectal Cancer Moon Shot are sharpening the focus of a genetic tool designed to classify colorectal cancer into one of four categories — a vital step toward improving treatment.
They’re addressing a challenge posed by the complexity of colon and rectal cancer, which leads to major differences in responses to treatment and patient survival.
“Some cancers have two or three very well-defined biomarkers...
In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic...
Early-stage breast cancer patients receiving a shorter course of whole-breast radiation with higher radiation doses reported equivalent cosmetic...
Proton therapy can deliver a higher radiation dose to lung tumors and a lower dose to healthy tissue compared to standard radiation therapy. However, the effectiveness of proton therapy has not yet been documented in clinical trials for patients with non–small cell lung cancer (NSCLC), the most common type of lung cancer. Two ongoing trials of proton therapy aim to demonstrate its effectiveness and may change the standard of care for...
Using an innovative approach to identify a cancer’s genetic vulnerabilities by more swiftly analyzing human tumors transplanted into mice,...
This summer, many preschoolers across Texas are safely enjoying their vacation time outdoors thanks to Ray and the Sunbeatables™, a sun-safety...
A mitogen-activated protein kinase (MAP) known as p38 appears to show promise for halting breast cancer metastasis, and may point to the potential...